RM Califf

2.1k total citations
40 papers, 1.6k citations indexed

About

RM Califf is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, RM Califf has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in RM Califf's work include Acute Myocardial Infarction Research (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Cardiac Imaging and Diagnostics (8 papers). RM Califf is often cited by papers focused on Acute Myocardial Infarction Research (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Cardiac Imaging and Diagnostics (8 papers). RM Califf collaborates with scholars based in United States, Canada and Australia. RM Califf's co-authors include Pryor Db, KL Lee, Harrell Fe, Mark A. Hlatky, Christopher B. Granger, Rankin Js, Jean‐Pierre Bassand, Smith Lr, John W. Eikelboom and Muhlbaier Lh and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

RM Califf

38 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
RM Califf United States	20	1.3k	632	321	280	170	40	1.6k
M. L. Simoons Netherlands	17	1.6k 1.3×	823 1.3×	509 1.6×	197 0.7×	115 0.7×	45	2.0k
Philip C. Adams United Kingdom	21	924 0.7×	390 0.6×	199 0.6×	258 0.9×	125 0.7×	67	1.5k
Robert H. Tuttle United States	15	1.3k 1.1×	1.1k 1.7×	394 1.2×	113 0.4×	72 0.4×	26	1.7k
Charles Lazzam Canada	15	1.2k 0.9×	948 1.5×	461 1.4×	146 0.5×	66 0.4×	27	1.5k
Lynn H. Woodlief United States	15	2.0k 1.6×	801 1.3×	831 2.6×	279 1.0×	134 0.8×	26	2.4k
Harm Wienbergen Germany	24	1.4k 1.1×	577 0.9×	411 1.3×	119 0.4×	98 0.6×	96	1.7k
Frank Vermeer Netherlands	19	2.1k 1.7×	941 1.5×	1.0k 3.2×	288 1.0×	185 1.1×	50	2.5k
Michel R. Le May Canada	25	1.7k 1.3×	885 1.4×	471 1.5×	213 0.8×	75 0.4×	61	2.1k
Leif Spange Mortensen Denmark	27	2.6k 2.1×	830 1.3×	686 2.1×	206 0.7×	184 1.1×	57	3.3k
Christopher B. Granger United States	20	2.0k 1.6×	276 0.4×	309 1.0×	613 2.2×	256 1.5×	40	2.2k

Countries citing papers authored by RM Califf

Since Specialization

Citations

This map shows the geographic impact of RM Califf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RM Califf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RM Califf more than expected).

Fields of papers citing papers by RM Califf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RM Califf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RM Califf. The network helps show where RM Califf may publish in the future.

Co-authorship network of co-authors of RM Califf

This figure shows the co-authorship network connecting the top 25 collaborators of RM Califf. A scholar is included among the top collaborators of RM Califf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RM Califf. RM Califf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baker‐Smith, Carissa M., et al.. (2008). Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis. Clinical Pharmacology & Therapeutics. 84(3). 315–319. 27 indexed citations

Rao, Sunil V., John W. Eikelboom, Christopher B. Granger, et al.. (2007). Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. European Heart Journal. 28(10). 1193–1204. 205 indexed citations

Miller, Chadwick D., Anjan K. Banerjee, Kenneth W. Mahaffey, et al.. (2007). Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial. European Heart Journal. 28(9). 1079–1084. 7 indexed citations

Califf, RM, RA Harrington, Marc Vallée, et al.. (2003). Higher Aspirin Dose is Associated with Reduced Mortality and More Serious Bleeding in Patients with Recent Cerebrovascular or Coronary Ischemic Events: Insights from the BRAVO Trial. Circulation. 108(17). 1 indexed citations

Harrington, RA, et al.. (2001). Diabetes doubles the risk of death among patients presenting with acute coronary syndromes: insights from SYMPHONY, a large international trial. Journal of the American College of Cardiology. 37(2). 1 indexed citations

Ohman, E. Magnus, Neal S. Kleiman, HD White, et al.. (2001). Optimal dosing of a glycoprotein IIb/IIIa antagonist with simplified renal-based algorithm: pharmacodynamic and clinical findings from PARAGON B. Journal of the American College of Cardiology. 37(2).

Alexander, John H., et al.. (2000). Higher aPTTs associated with worse outcomes after thrombolytic therapy with reduced-dose heparin: results from Assent-2. Journal of the American College of Cardiology. 35(2). 2 indexed citations

Harrington, RA, Frans Van de Werf, Andrew Keech, et al.. (1997). Delaying and Preventing Ischemic Events in Patients with Acute Coronary Syndromes Using the Platelet Glycoprotein IIb/IIIa Inhibitor Lamifiban. Journal of the American College of Cardiology. 29. 8 indexed citations

Harrington, RA, Frans Van de Werf, John Simes, et al.. (1997). Amplification of clinical benefit at six months with the glycoprotein IIb/IIIa inhibitor lamifiban in patients with non ST segment elevation in acute coronary syndromes. Circulation. 96(8). 4 indexed citations

10.

Werf, Frans Van de, et al.. (1995). Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. European Heart Journal. 16(8). 1024–1026. 4 indexed citations

11.

Califf, RM, Eric J. Topol, Frans Van de Werf, & KL Lee. (1994). One year followup from the GUSTO I trial. Circulation. 90(4). 5 indexed citations

12.

Lr, Smith, Harrell Fe, Rankin Js, et al.. (1991). Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery.. PubMed. 84(5 Suppl). III245–53. 122 indexed citations

13.

Hlatky, Mark A., et al.. (1990). Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery.. PubMed. 82(5 Suppl). IV208–13. 66 indexed citations

14.

Topol, Eric J., et al.. (1990). Failure of conservative management post-thrombolysis: Profile of the TAMI-5 crossover population. Journal of the American College of Cardiology. 15(2). A63–A63. 2 indexed citations

15.

Cummings, Robin G., K A Reimer, RM Califf, et al.. (1988). Quantitative analysis of right and left ventricular infarction in the presence of postinfarction ventricular septal defect.. Circulation. 77(1). 33–42. 65 indexed citations

16.

Mark, DB, Mark A. Hlatky, Harrell Fe, et al.. (1988). Surgical survival benefits for coronary disease patients with left ventricular dysfunction.. PubMed. 78(3 Pt 2). I151–7. 105 indexed citations

17.

Lr, Smith, Muhlbaier Lh, Harrell Fe, et al.. (1988). Current prognosis of ischemic mitral regurgitation. Implications for future management.. PubMed. 78(3 Pt 2). I51–9. 177 indexed citations

18.

Califf, RM, et al.. (1985). Clinical Databases: Accomplishments and Unrealized Potential. Medical Care. 23. 13 indexed citations

19.

Godwin, J. David, et al.. (1984). Prospective demonstration of myocardial infarction by CT. American Journal of Roentgenology. 143(5). 985–986. 5 indexed citations

20.

Mark, Daniel B., et al.. (1984). Clinical characteristics and long-term survival of patients with variant angina.. Circulation. 69(5). 880–888. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact